ATE319741T1 - Gereinigte thrombopoietin und verfahren zur herstellung davon - Google Patents

Gereinigte thrombopoietin und verfahren zur herstellung davon

Info

Publication number
ATE319741T1
ATE319741T1 AT95943915T AT95943915T ATE319741T1 AT E319741 T1 ATE319741 T1 AT E319741T1 AT 95943915 T AT95943915 T AT 95943915T AT 95943915 T AT95943915 T AT 95943915T AT E319741 T1 ATE319741 T1 AT E319741T1
Authority
AT
Austria
Prior art keywords
thrombopoietin
proteins
eluted
producing
purified
Prior art date
Application number
AT95943915T
Other languages
English (en)
Inventor
John W Forstrom
Catherine E Lofton-Day
Si Lok
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE319741T1 publication Critical patent/ATE319741T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95943915T 1994-12-30 1995-12-20 Gereinigte thrombopoietin und verfahren zur herstellung davon ATE319741T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36685994A 1994-12-30 1994-12-30

Publications (1)

Publication Number Publication Date
ATE319741T1 true ATE319741T1 (de) 2006-03-15

Family

ID=23444867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95943915T ATE319741T1 (de) 1994-12-30 1995-12-20 Gereinigte thrombopoietin und verfahren zur herstellung davon

Country Status (11)

Country Link
US (1) US5986049A (de)
EP (1) EP0804480B1 (de)
JP (1) JPH10511681A (de)
CN (1) CN1171791A (de)
AT (1) ATE319741T1 (de)
AU (1) AU4526096A (de)
CA (1) CA2207577A1 (de)
DE (1) DE69534853D1 (de)
MX (1) MX9703959A (de)
NZ (1) NZ300500A (de)
WO (1) WO1996020955A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990081421A (ko) * 1998-04-29 1999-11-15 성재갑 동물세포를 이용한 인간 혈소판 생성 촉진인자(tpo)의 제조방법
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
CA2424029C (en) 2000-09-29 2008-01-29 Cordis Corporation Coated medical devices
US20040028661A1 (en) * 2002-08-07 2004-02-12 Bartelmez Stephen H. Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
KR100473703B1 (ko) * 2002-08-23 2005-03-10 한미약품 주식회사 형질전환 동물의 젖으로부터 재조합 펩타이드 또는단백질의 정제 방법
CN100432102C (zh) * 2004-09-30 2008-11-12 百瑞全球有限公司 血小板增进蛋白及其应用
ZA200704252B (en) * 2004-10-25 2009-09-30 Cellerant Therapeutics Inc Methods of expanding myeloid cell populations and uses thereof
US7879318B2 (en) * 2006-01-23 2011-02-01 Mcw Research Foundation, Inc. Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand
CN102033010B (zh) * 2010-11-26 2013-02-20 四川农业大学 一种垂直板电泳中凝胶点样顺序及凝胶顺序的双重标示方法
CN105541994B (zh) * 2015-12-01 2019-12-06 沈阳三生制药有限责任公司 一种血小板生成素或其变体或衍生物的纯化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7972991A (en) * 1990-05-31 1991-12-31 Meiji Seika Kaisha Ltd. Novel megakaryocyte colony stimulating factor and production thereof
GB2285446B (en) * 1994-01-03 1999-07-28 Genentech Inc Thrombopoietin
US5541085A (en) * 1994-02-14 1996-07-30 Zymogenetics, Inc. Method for preparing orphan receptor ligands
WO1995021919A2 (en) * 1994-02-14 1995-08-17 Kirin Brewery Company, Limited Protein having tpo activity
GEP20002180B (en) * 1994-03-31 2000-07-25 Amgen Inc Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation

Also Published As

Publication number Publication date
CA2207577A1 (en) 1996-07-11
WO1996020955A1 (en) 1996-07-11
AU4526096A (en) 1996-07-24
MX9703959A (es) 1998-01-31
US5986049A (en) 1999-11-16
CN1171791A (zh) 1998-01-28
DE69534853D1 (de) 2006-05-04
JPH10511681A (ja) 1998-11-10
NZ300500A (en) 1999-04-29
EP0804480A1 (de) 1997-11-05
EP0804480B1 (de) 2006-03-08

Similar Documents

Publication Publication Date Title
Burke et al. Synthesis of types I and III procollagen and collagen by monkey aortic smooth muscle cells in vitro
Lui et al. Identification of the bovine follicular fluid protein involved in the in vitro induction of the hamster sperm acrosome reaction
Wolfgram et al. THE COMPOSITION OF THE MYELIN PROTEINS OF THE CENTRAL NERVOUS SYSTEM 1 2
ATE319741T1 (de) Gereinigte thrombopoietin und verfahren zur herstellung davon
ATE249840T1 (de) Verfahren und materialien zur herstellung von modifizierten variablen antikörperdomänen und ihre therapeutische verwendung
AU702557C (en) Novel protein and methods for producing the proteins
DE122009000068I1 (de) Verfahren zur Herstellung von heterologen bispezifischen Antikörpern
ATE45382T1 (de) Biosynthetisch hergestellter humannervenwachstumsfaktor, verfahren zu seiner herstellung, diesen faktor enthaltende zusammensetzungen, diesen faktor codierende dna- sequenz, vektoren, die diese sequenz enthalten und dadurch transformierte wirtszellen.
ATE122054T1 (de) Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
ATE68830T1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
ATA181986A (de) Verfahren zur herstellung von neuen substituierten androsta-1,4-dien-3,17-dionen
ATE142255T1 (de) Verfahren zur herstellung eines aktivierten faktor vii-konzentrates mit einer hohen reinheit
DE3783991D1 (de) Testverfahren und diagnostisches system zur bestimmung des abnormalen fettstoffwechsels.
AU656552B2 (en) Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction
Abe et al. Purification of rabbit tumor necrosis factor
DE69532588D1 (de) Verfahren zur verbesserung der immunogenität einer immunogenen zusammensetzung oder eines haptens und verwendung zur herstellung von impfstoffen
KR890701618A (ko) 단백질 정제방법
Sugimoto et al. Differential acceleration by hydrocortisone of the accumulation of epidermal structural proteins in the chick embryonic skin growing in a chemically defined medium
ATE71110T1 (de) Verfahren zur reinigung eines proteins.
Agrawal et al. In vivo phosphorylation of two myelin basic proteins of developing rabbit brain.
Beato et al. Hormone-dependent synthesis and secretion of uteroglobin in isolated rabbit uterus
DE68922790D1 (de) Verfahren zur Herstellung eines Proteins durch Hefe mit Hilfe eines induzierbaren Systems, Vektoren und entsprechende transformierte Stämme.
Amrani et al. Structural analysis of fibrinogen synthesized by cultured chicken hepatocytes in the presence or absence of dexamethasone
ATE272072T1 (de) Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli
KR960703943A (ko) 신규단백질 및 그 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties